ROCHESTER, Minn. — Mayo Clinic is making it easier for industry sponsors and investigators at sites across the country to collaborate with Mayo on complex and groundbreaking research studies and clinical trials.
In a move aimed at optimizing accur…
Berkeley — Girls in homes without a biological father are more likely to hit puberty at an earlier age, according to a new study led by researchers at the University of California, Berkeley’s School of Public Health.
The findings, to be publis…
Scientists at Washington University School of Medicine in St. Louis have discovered a new drug target that could improve the effectiveness of radiation for hard-to-treat cancers.
The finding, published in the Journal of the National Cancer Institu…
SEATTLE — It is well known that exposure to radiation has multiple harmful effects — including causing cancer — but until now, it has been unclear to what extent such exposure increases a person’s risk of developing more than one cancer.
The …
EAST LANSING, Mich. — Girls eating a high-fat diet during puberty, even those who do not become overweight or obese, may be at a greater risk of developing breast cancer later in life, according to Michigan State University researchers.
The imp…
Patients with the earliest form of the most common type of lung cancer are more than twice as likely to die of the disease within four years if they have a mutation in a well known cancer-causing gene, scientists have found. The study in the July 2 issue of the Journal of the National Cancer Institute also shows that lung cancer patients who both smoke and consume alcohol frequently are more likely to have the mutation.
In patients with metastatic breast cancer, immune cells from a genetically matched donor can attack and shrink tumors, researchers from the National Cancer Institute (NCI) announced today at the Annual Meeting of the American Society of Clinical Oncology in Chicago. This is the first time researchers have clearly demonstrated this type of immune response, known as a graft-versus-tumor effect, acting against breast cancer.
Smokers and drinkers who take beta-carotene supplements to help prevent cancer may actually increase their risk, new research finds. The study, led by Dartmouth Medical School (DMS), provides a cautionary perspective regarding the alleged cancer-fighting attributes of beta-carotene and other antioxidants. It is published in the May 21 issue of the Journal of the National Cancer Institute.
Exposure to certain agricultural pesticides may be associated with an increased risk of prostate cancer among pesticide applicators, according to a large study looking at the causes of cancer and other diseases in the farming community. The study, part of a long-term study of pesticide applicators and their spouses known as the Agricultural Health Study (AHS), appears in the May 1, 2003, issue of the American Journal of Epidemiology*. The AHS is a collaborative effort involving the National Cancer Institute (NCI), the National Institute of Environmental Health Sciences, and the Environmental Protection Agency.
A research team led by The University of Texas M. D. Anderson Cancer Center has tested a novel “viral smart bomb” therapy that can completely eradicate brain tumors in mice, while leaving normal brain tissue alone. The therapy, known as Delta-24-RGD, is thought to be the first treatment for malignant glioma, the deadliest form of brain cancer. It is a new-generation “replication-competent oncolytic” adenovirus therapy ?? defined as a therapeutic virus that can spread, wavelike, throughout a tumor, infecting and killing cancer cells. There is no adequate treatment for these deadly brain cancers and, before this study, few experimental therapies tested in animals have shown much improvement.
A New jersey researcher has discovered a gene responsible for melanoma, the most aggressive form of malignant skin cancer. Melanoma may appear in places that never see sun, spread to other parts of the body and become lethal. This type of cancer is not generally responsive to chemotherapy. Cancer Institute, in the United States the incidence rate of melanoma has more than doubled in the past 20 years.